Angelo Palmas

1.3k total citations
18 papers, 486 citations indexed

About

Angelo Palmas is a scholar working on Hematology, Molecular Biology and Oncology. According to data from OpenAlex, Angelo Palmas has authored 18 papers receiving a total of 486 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hematology, 5 papers in Molecular Biology and 4 papers in Oncology. Recurrent topics in Angelo Palmas's work include Multiple Myeloma Research and Treatments (6 papers), Hematopoietic Stem Cell Transplantation (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Angelo Palmas is often cited by papers focused on Multiple Myeloma Research and Treatments (6 papers), Hematopoietic Stem Cell Transplantation (4 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). Angelo Palmas collaborates with scholars based in Italy, United States and Czechia. Angelo Palmas's co-authors include Giovanna Piras, Maria Monne, David J. Inwards, Dennis A. Gastineau, James G. Scott, Attilio Gabbas, Mark R. Litzow, Martha Q. Lacy, Ayalew Tefferi and Stephen J. Swensen and has published in prestigious journals such as Journal of Clinical Oncology, Blood and JNCI Journal of the National Cancer Institute.

In The Last Decade

Angelo Palmas

17 papers receiving 478 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Angelo Palmas Italy 8 216 141 125 122 111 18 486
Mitsutoshi Kurosawa Japan 13 209 1.0× 241 1.7× 140 1.1× 108 0.9× 68 0.6× 49 610
Masaaki Kumagai Japan 12 164 0.8× 242 1.7× 125 1.0× 111 0.9× 67 0.6× 28 633
Sumie Tabata Japan 13 137 0.6× 101 0.7× 141 1.1× 113 0.9× 45 0.4× 49 449
Vera Malkovska United States 13 155 0.7× 211 1.5× 84 0.7× 279 2.3× 56 0.5× 43 623
Vivek A. Bhadri Australia 13 187 0.9× 84 0.6× 63 0.5× 70 0.6× 160 1.4× 35 559
Yoshihito Hayami Japan 13 154 0.7× 155 1.1× 197 1.6× 161 1.3× 82 0.7× 26 583
M. Yadira Hurley United States 15 229 1.1× 93 0.7× 144 1.2× 86 0.7× 42 0.4× 52 651
Denise Pereira United States 12 235 1.1× 175 1.2× 103 0.8× 51 0.4× 41 0.4× 37 536
Ken Gatter United States 16 158 0.7× 130 0.9× 94 0.8× 48 0.4× 114 1.0× 31 498
Keisuke Kawamoto Japan 14 245 1.1× 99 0.7× 279 2.2× 215 1.8× 47 0.4× 48 646

Countries citing papers authored by Angelo Palmas

Since Specialization
Citations

This map shows the geographic impact of Angelo Palmas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Angelo Palmas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Angelo Palmas more than expected).

Fields of papers citing papers by Angelo Palmas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Angelo Palmas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Angelo Palmas. The network helps show where Angelo Palmas may publish in the future.

Co-authorship network of co-authors of Angelo Palmas

This figure shows the co-authorship network connecting the top 25 collaborators of Angelo Palmas. A scholar is included among the top collaborators of Angelo Palmas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Angelo Palmas. Angelo Palmas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

18 of 18 papers shown
1.
2.
Grandi, Nicole, Roberto Cusano, Giovanna Piras, et al.. (2024). The impact of insularity on SARS-CoV-2 diffusion: Recapitulating three years of COVID-19 pandemic in the island of Sardinia. Journal of Infection and Public Health. 17(8). 102496–102496. 1 indexed citations
3.
Piras, Giovanna, Maria Monne, Maura Fiamma, et al.. (2022). Molecular Characterization of Severe Acute Respiratory Syndrome Coronavirus 2 Isolates From Central Inner Sardinia. Frontiers in Microbiology. 12. 827799–827799. 3 indexed citations
4.
Monne, Maria, Giovanna Piras, Roberto Cusano, et al.. (2022). Expression Profiles of Human Endogenous Retrovirus in Chronic Myeloid Leukemia at Diagnosis and after TKI Therapy. Blood. 140(Supplement 1). 12175–12177. 1 indexed citations
5.
Piras, Giovanna, Nicole Grandi, Maria Monne, et al.. (2021). Early Diffusion of SARS-CoV-2 Infection in the Inner Area of the Italian Sardinia Island. Frontiers in Microbiology. 11. 628194–628194. 2 indexed citations
6.
Foà, Robin, Pellegrino Musto, Chiara Cerrato, et al.. (2018). Updated efficacy data and MRD analysis according to risk status in newly diagnosed myeloma patients treated with carfilzomib + lenalidomide or cyclophosphamide (FORTE trial).. Journal of Clinical Oncology. 36(15_suppl). 8009–8009. 3 indexed citations
7.
Palmas, Angelo, et al.. (2017). Pomalidomide in Heavily Pretreated Refractory Multiple Myeloma: A Case Report. Future Oncology. 13(sup5). 7–9. 1 indexed citations
8.
Scalabrini, Delia Rota, Angelo Belotti, Massimo Offidani, et al.. (2017). Carfilzomib-lenalidomide-dexamethasone (KRd) vs carfilzomib-cyclophosphamide-dexamethasone (KCd) induction: Planned interim analysis of the randomized FORTE trial in newly diagnosed multiple myeloma (NDMM).. Journal of Clinical Oncology. 35(15_suppl). 8003–8003. 14 indexed citations
9.
Baronciani, D, Clara Targhetta, Daniele Derudas, et al.. (2015). Treosulfan-fludarabine-thiotepa conditioning before allogeneic haemopoietic stem cell transplantation for patients with advanced lympho-proliferative disease. A single centre study. Hematological Oncology. 34(1). 17–21. 4 indexed citations
10.
Piras, Giovanna, Maria Monne, Angelo Palmas, et al.. (2014). Methylation analysis of the phosphates and tensin homologue on chromosome 10 gene (PTEN) in multiple myeloma. Clinical Epigenetics. 6(1). 16–16. 15 indexed citations
11.
Cocco, Pierluigi, Giovanna Piras, Maria Monne, et al.. (2008). Risk of malignant lymphoma following viral hepatitis infection. International Journal of Hematology. 87(5). 474–483. 22 indexed citations
12.
Piras, Giovanna, et al.. (2008). Methylation of the PTEN Promoter Leads to PTEN Inactivation in Multiple Myeloma. Blood. 112(11). 2717–2717. 1 indexed citations
13.
Ferreri, Andrés J.M., Maurilio Ponzoni, Massimo Guidoboni, et al.. (2006). Bacteria-Eradicating Therapy With Doxycycline in Ocular Adnexal MALT Lymphoma: A Multicenter Prospective Trial. JNCI Journal of the National Cancer Institute. 98(19). 1375–1382. 145 indexed citations
14.
Piras, Giovanna, Maria Monne, Angelo Palmas, et al.. (2005). Genetic analysis of the 2q33 region containing CD28–CTLA4–ICOS genes: association with non‐Hodgkin's lymphoma. British Journal of Haematology. 129(6). 784–790. 35 indexed citations
15.
Monne, Maria, et al.. (2004). Cytotoxic T‐lymphocyte antigen‐4 (CTLA‐4) gene polymorphism and susceptibility to non‐Hodgkin's lymphoma. American Journal of Hematology. 76(1). 14–18. 71 indexed citations
16.
Montillo, Marco, Alessandra Tedeschi, Livio Pagano, et al.. (2000). Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group. British Journal of Haematology. 111(1). 334–337. 17 indexed citations
17.
Montillo, Marco, Alessandra Tedeschi, Livio Pagano, et al.. (2000). Feasibility of peripheral blood stem cell rescue as intensification in elderly patients with acute myelocytic leukaemia: a pilot study from the Gimema Group. British Journal of Haematology. 111(1). 334–337. 4 indexed citations
18.
Palmas, Angelo, Ayalew Tefferi, Jeffrey L. Myers, et al.. (1998). Late‐onset noninfectious pulmonary complications after allogeneic bone marrow transplantation. British Journal of Haematology. 100(4). 680–687. 147 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mitsutoshi Kurosawa Breakdown of academic impact, for papers by Masaaki Kumagai Breakdown of academic impact, for papers by Sumie Tabata Breakdown of academic impact, for papers by Vera Malkovska Breakdown of academic impact, for papers by Vivek A. Bhadri Breakdown of academic impact, for papers by Yoshihito Hayami Breakdown of academic impact, for papers by M. Yadira Hurley Breakdown of academic impact, for papers by Denise Pereira Breakdown of academic impact, for papers by Ken Gatter Breakdown of academic impact, for papers by Keisuke Kawamoto
Rankless by CCL
2026